ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 154 filers reported holding ACCELERON PHARMA INC in Q3 2017. The put-call ratio across all filers is 4.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,064,000 | -59.8% | 35,000 | -65.0% | 0.18% | -65.0% |
| Q1 2017 | $2,647,000 | +3.7% | 100,000 | 0.0% | 0.52% | -20.0% |
| Q4 2016 | $2,552,000 | -12.8% | 100,000 | +66.7% | 0.65% | +50.9% |
| Q4 2015 | $2,926,000 | +17.5% | 60,000 | -40.0% | 0.43% | +34.6% |
| Q3 2015 | $2,490,000 | -21.3% | 100,000 | 0.0% | 0.32% | +2.6% |
| Q2 2015 | $3,164,000 | +4.6% | 100,000 | 0.0% | 0.31% | -17.1% |
| Q3 2014 | $3,024,000 | +338.3% | 100,000 | +400.0% | 0.37% | +136.7% |
| Q1 2014 | $690,000 | -65.2% | 20,000 | -60.0% | 0.16% | -71.4% |
| Q4 2013 | $1,980,000 | – | 50,000 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 1,400,000 | $133,378,000 | 3.73% |
| Foresite Capital Management III, LLC | 42,030 | $4,004,000 | 3.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 257,249 | $24,508,000 | 2.23% |
| Cormorant Asset Management, LP | 600,000 | $57,162,000 | 2.18% |
| Avoro Capital Advisors LLC | 1,040,000 | $99,081,000 | 1.96% |
| QVT Financial LP | 101,396 | $9,660,000 | 1.64% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,100,000 | $200,067,000 | 1.60% |
| Rhenman & Partners Asset Management AB | 155,000 | $14,767,000 | 1.60% |
| Parkman Healthcare Partners LLC | 57,500 | $5,478,000 | 1.54% |
| Ikarian Capital, LLC | 187,700 | $17,882,000 | 1.42% |